News & Information
“Anti-Semaphorin 3A neutralization monoclonal antibody prevents sepsis development in lipopolysaccharide-treated mice ” by Yamashita et al(Int Immunol, 2015). Research Results |
”A novel Semaphorin3A signaling mediated through dynamic conformational change associated with filamin-A and CRMP1 interaction” by Nakamura et al (Nat Commun, 2014). http://www.ncbi.nlm.nih.gov/pubmed/25358863 |
”Life innovation and future healthcare system” presented by Prof Goshima in Smart City 2014 at Yokohama Convention Center. |
The 131st Kanto Branch Meeting, Japanese Pharmacology was held in Yokohama City University, Sch of Med (Fuku-ura campus) Chair, Prof Yoshio Goshima, MD&PhD (Dept of Mol Pharmacol&Neurobiol) |
”A retrograde Sema3A signaling propagated from local growth cone regulates dendritic localization of GluA2 subunit-containing AMPA receptors ” by Yamashita et al (Nat Commun, 2014). http://www.ncbi.nlm.nih.gov/pubmed/24599038 |